Literature DB >> 15846278

B-type natriuretic peptide levels are not a surrogate marker for invasive hemodynamics during management of patients with severe heart failure.

J O O'Neill1, C E Bott-Silverman, A T McRae, R W Troughton, K Ng, R C Starling, J B Young.   

Abstract

BACKGROUND: We sought to assess the utility of serial BNP measurements in patients with severe heart failure and attempted to correlate values with invasively derived data.
METHODS: In a retrospective study, we analyzed serial BNP levels in patients receiving hemodynamically guided therapy for severe heart failure and sought correlation with invasively derived data.
RESULTS: Thirty-nine patients with New York Heart Association Class III-IV, with an ejection fraction of 35% or less, who had a pulmonary artery catheter inserted for hemodynamically tailored heart failure therapy, were identified and serial BNP measurements reviewed. BNP was estimated on admission, at 12 and 36 hours. Normally distributed variables are expressed as mean +/- SD and otherwise as median +/- interquartile range. Mean ejection fraction was 16% +/- 6%. Mean pulmonary artery occlusion pressures (PAOP) fell with therapy and were 25 +/- 7 mmHg, 18 +/- 7 mmHg and 19 +/- 7 mmHg at admission, 12 hours and 36 hours respectively ( P < 0.05). Median BNP levels fell from 1200 +/- 641 to 771 +/- 803 at 12 hours and to 805 +/- 771 at 36 hours (P < .001). There was no correlation between BNP and any hemodynamically derived variable. A change in BNP was not associated with a change in PAOP in any individual patient. Only 42% remained alive on medical therapy at 30 days.
CONCLUSIONS: In patients with severe heart failure, BNP levels do not accurately predict serial hemodynamic changes and do not obviate the need for pulmonary artery catheterization.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15846278     DOI: 10.1016/j.ahj.2004.05.051

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  10 in total

1.  Utility of thoracic sonography for follow-up examination of chronic heart failure patients with previous decompensation.

Authors:  Hajime Kataoka
Journal:  Clin Cardiol       Date:  2007-07       Impact factor: 2.882

2.  Institute for Quality in Laboratory Medicine series--controversies in laboratory medicine: insights into B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide measurements.

Authors:  Robert H Christenson; W H Wilson Tang
Journal:  MedGenMed       Date:  2006-05-31

Review 3.  Right heart catheterization and risk stratification in advanced heart failure.

Authors:  Michael Craig; Naveen L Pereira
Journal:  Curr Heart Fail Rep       Date:  2006-09

4.  Influence of acute and chronic myocardial loading conditions, function, structural changes and extracardiac factors on NT-proBNP in asymptomatic patients with preserved ejection fraction.

Authors:  Olaf Schulz; Andre Rudolph; Sarah Scheiner; Helena Mut; Jeanette Schulz-Menger; Gunnar Berghoefer; Ricarda Bensch; Jochen Kraemer; Ingolf Schimke
Journal:  Clin Res Cardiol       Date:  2010-09-02       Impact factor: 5.460

5.  The impact of cardiac resynchronization therapy on obstructive sleep apnea in heart failure patients: a pilot study.

Authors:  Michael L Stanchina; Kristin Ellison; Atul Malhotra; Maria Anderson; Malcolm Kirk; Michael E Benser; Christine Tosi; Carol Carlisle; Richard P Millman; Alfred Buxton
Journal:  Chest       Date:  2007-06-15       Impact factor: 9.410

6.  Changes in brain natriuretic peptide are correlated with changes in global end-diastolic volume index.

Authors:  Zhongheng Zhang; Hongying Ni; Baolong Lu; Xiao Xu
Journal:  J Thorac Dis       Date:  2013-04       Impact factor: 2.895

7.  Relevance of short-term variation of B-type natriuretic peptide in patients with clinically stable heart failure.

Authors:  Micha Tobias Maeder; Dietrich Hack; Hans Rickli; Hans Peter Brunner-La Rocca; Walter Riesen; Peter Ammann
Journal:  Wien Klin Wochenschr       Date:  2008       Impact factor: 1.704

Review 8.  Similar hemodynamic decongestion with vasodilators and inotropes: systematic review, meta-analysis, and meta-regression of 35 studies on acute heart failure.

Authors:  Shiro Ishihara; Etienne Gayat; Naoki Sato; Mattia Arrigo; Said Laribi; Matthieu Legrand; Rui Placido; Philippe Manivet; Alain Cohen-Solal; William T Abraham; Mariell Jessup; Alexandre Mebazaa
Journal:  Clin Res Cardiol       Date:  2016-06-17       Impact factor: 5.460

Review 9.  Interpretation of B-type natriuretic peptide in cardiac disease and other comorbid conditions.

Authors:  Michael A Burke; William G Cotts
Journal:  Heart Fail Rev       Date:  2007-03-08       Impact factor: 4.654

10.  High-sensitivity troponin T: a biomarker for diuretic response in decompensated heart failure patients.

Authors:  João Pedro Ferreira; Mário Santos; Sofia Almeida; Irene Marques; Paulo Bettencourt; Henrique Carvalho
Journal:  Cardiol Res Pract       Date:  2014-08-28       Impact factor: 1.866

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.